Company page

Sophia Genetics Sa

Sophia Genetics SA is a public company traded under the ticker SOPH in the American market, with a market capitalization of approximately $391.3 million. The company specializes in data-driven medicine, leveraging advanced analytics to enhance genomic and clinical data interpretation. Sophia Genetics aims to improve patient outcomes through its innovative technology and solutions in the field of healthcare.